US pharma giant Merck & Co (NYSE: MRK) today announced that the Phase III KEYNOTE-B96 trial, also known as ENGOT-ov65, met ...

The integration of genomics into the pharmaceutical industry has allowed researchers to better understand the genetic factors ...

In a world where western firms increasingly seek to ingratiate themselves with Middle Eastern leaders and investors, a Saudi ...

Emrelis (telisotuzumab vedotin-tllv) has been granted accelerated approval by the US Food and Drug Administration (FDA), said ...

London-based specialty pharmaceutical company CNX Therapeutics is set to fast-track its European growth strategy after being ...

US Department of Health and Human Services (HHS) Secretary Robert F Kennedy Jr (RFK Jr) has spoken in defence of his proposed ...

Swedish biotech firm PeptiSystems has joined forces with Asahi Kasei Bioprocess America in a global partnership set to ...

German pharmaceutical company Boehringer Ingelheim has entered a multi-year collaboration with Tempus AI (Nasdaq: TEM), ...

Aiming to expand its hepatology portfolio, UK pharma major GSK (LSE: GSK) yesterday announced that it has entered into an ...

Marking the latest move to pledge to spend billions of dollars into the USA, French pharm major Sanofi (Euronext: SAN) ...

Japanese pharma major Takeda (TYO: 4502) announced that the US Food and Drug Administration (FDA) has accepted for priority ...

Danish dermatology specialist LEO Pharma today released financial results for the first-quarter of 2025, noting its continued ...